Mon. 18 Mar 2024, 11:02am ET
Benzinga
Biotech, News, General
- SHPH Dashboard
- Financials
- Filings
- Insider
- News
-
Article
Shuttle Pharmaceuticals Has Been Granted European Patent Number EP3737376 Titled "Selective Histone Deacetylase Inhibitors For The Treatment Of Human Diseases (Including Cancers, Neurological Disorders, And Immunological Disorders)"
Company Profile